RJFSA
NVCR icon

Raymond James Financial Services Advisors’s NovoCure NVCR Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,789
Closed -$365K – 3309
2023
Q2 		$365K Sell
8,789
-3,442
-28% -$214K ﹤0.01% 2536
2023
Q1 		$736K Buy
12,231
+770
+7% +$61.5K ﹤0.01% 2102
2022
Q4 		$841K Buy
11,461
+712
+7% +$53.6K ﹤0.01% 1949
2022
Q3 		$817K Sell
10,749
-139
-1% -$10.8K ﹤0.01% 1941
2022
Q2 		$757K Sell
10,888
-298
-3% -$22.4K ﹤0.01% 2013
2022
Q1 		$927K Sell
11,186
-555
-5% -$40.9K ﹤0.01% 2011
2021
Q4 		$882K Sell
11,741
-8,632
-42% -$866K ﹤0.01% 2052
2021
Q3 		$2.37M Sell
20,373
-4,078
-17% -$617K ﹤0.01% 1387
2021
Q2 		$5.42M Buy
24,451
+292
+1% +$56.8K 0.01% 933
2021
Q1 		$3.19M Sell
24,159
-1,302
-5% -$206K 0.01% 1132
2020
Q4 		$4.41M Sell
25,461
-90
-0.4% -$12.3K 0.01% 890
2020
Q3 		$2.84M Buy
25,551
+469
+2% +$37.5K 0.01% 997
2020
Q2 		$1.49M Sell
25,082
-7,523
-23% -$495K ﹤0.01% 1254
2020
Q1 		$2.2M Sell
32,605
-1,429
-4% -$113K 0.01% 847
2019
Q4 		$2.87M Buy
34,034
+3,290
+11% +$266K 0.01% 993
2019
Q3 		$2.3M Buy
30,744
+11,359
+59% +$908K 0.01% 1035
2019
Q2 		$1.23M Buy
19,385
+127
+0.7% +$6.43K ﹤0.01% 1387
2019
Q1 		$928K Sell
19,258
-1,733
-8% -$83.4K ﹤0.01% 1503
2018
Q4 		$703K Buy
20,991
+513
+3% +$18.8K ﹤0.01% 1464
2018
Q3 		$1.07M Buy
20,478
+11,120
+119% +$443K ﹤0.01% 1423
2018
Q2 		$293K Buy
+9,358
New +$260K ﹤0.01% 2250

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Raymond James Financial Services Advisors's NVCR Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 8,789 shares — an estimated $365K sold.

Raymond James Financial Services Advisors first reported a position in NVCR in Q2 2018 and held it in 21 quarters. The position peaked at $5.42M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Raymond James Financial Services Advisors reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 8,789 NovoCure shares in Q3 2023, an estimated $365K.
  • Raymond James Financial Services Advisors first reported a position in NovoCure in Q2 2018 and held it in 21 quarters.
  • Raymond James Financial Services Advisors's NovoCure position peaked at $5.42M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.